| http://www.w3.org/ns/prov#value | - The term ???pharmaceutically acceptable carrier??? or ???carrier??? includes any material which, when combined with AT2 receptor antagonist, allows the AT2 receptor antagonist compound to retain biological activity, such as the ability to decrease, inhibit, or modulate the biological activity of an Agtr2 gene or an expression product thereof including an AT2 receptor polypeptide, and is non-reacti
|
